PACB earnings
Pacific Biosciences (PACB) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
PACB earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 3, 2026 | -0.14 | -0.13 | -9.38% | $39.01M |
| Q1 2026 | May 7, 2026 | -0.03 | -0.17 | 82.35% | $37.18M |
| Q4 2025 | Feb 12, 2026 | -0.12 | -0.19 | 36.84% | $44.65M |
| Q3 2025 | Nov 5, 2025 | -0.12 | -0.16 | 25.00% | $38.44M |
| Q2 2025 | Aug 7, 2025 | -0.13 | -0.18 | 27.78% | $39.77M |
| Q1 2025 | May 8, 2025 | -1.44 | -0.19 | -657.89% | $37.15M |
| Q4 2024 | Feb 13, 2025 | -0.20 | -0.20 | 0.00% | $39.22M |
| Q3 2024 | Nov 7, 2024 | -0.22 | -0.22 | 0.00% | $39.97M |
| Q2 2024 | Aug 6, 2024 | -0.64 | -0.24 | -166.67% | $36.01M |
| Q1 2024 | May 9, 2024 | -0.29 | -0.28 | -3.57% | $38.81M |
| Q4 2023 | Feb 15, 2024 | -0.31 | -0.29 | -6.90% | $58.36M |
| Q3 2023 | Oct 30, 2023 | -0.26 | -0.33 | 21.21% | $55.69M |
| Aug 2, 2023 | -0.28 | -0.32 | 12.50% | – | |
| May 2, 2023 | -0.36 | -0.33 | -9.09% | – | |
| Feb 16, 2023 | -0.37 | -0.36 | -2.78% | – | |
| Nov 7, 2022 | -0.34 | -0.33 | -3.03% | – | |
| Aug 3, 2022 | -0.32 | -0.32 | 0.00% | – | |
| May 4, 2022 | -0.37 | -0.31 | -19.35% | – | |
| Feb 15, 2022 | -0.31 | -0.28 | -10.71% | – | |
| Nov 2, 2021 | -0.23 | -0.21 | -9.52% | – |
- PACB reports next on Nov 3, 2026, with EPS of -0.15 expected.
- PACB beat EPS estimates in 35 of its last 58 reports.
Updated 2026-11-03 00:47 UTC